# Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

> **NCT07363369** · PHASE1 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumors

## Interventions

- **BIOLOGICAL:** FAP mRNA vaccine (dose 1) + immune checkpoint inhibitors
- **BIOLOGICAL:** FAP mRNA vaccine (dose 2) + immune checkpoint inhibitors
- **BIOLOGICAL:** FAP mRNA vaccine (dose 3) + immune checkpoint inhibitors
- **BIOLOGICAL:** FAP mRNA vaccine (dose 4) + immune checkpoint inhibitors

## Key facts

- **NCT ID:** NCT07363369
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07363369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07363369, "Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07363369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*